2025 · 3rd Quarter (July 1 - Sep 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by RADIUS ADVOCACY, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 7, 2025
Income: $30,000.00
Expenses: Not reported
Registrant: RADIUS ADVOCACY, LLC
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filing UUID: d7bf55f9-04c1-4d1c-ad5d-d1ac3dd037fa
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

CPT · Copyright/Patent/Trademark

Patent rights. Merchant rights.

PHA · Pharmacy

Issues realted to anti-competitive tactics in the pharmaceutical marketplace. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act.

Literal federal measure citations: S.1040, S.1041

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.